WO2018026087A3 - 당 부가된 엔클로미펜, 이의 제조방법 및 이를 포함하는 약학적 조성물 - Google Patents
당 부가된 엔클로미펜, 이의 제조방법 및 이를 포함하는 약학적 조성물 Download PDFInfo
- Publication number
- WO2018026087A3 WO2018026087A3 PCT/KR2017/004022 KR2017004022W WO2018026087A3 WO 2018026087 A3 WO2018026087 A3 WO 2018026087A3 KR 2017004022 W KR2017004022 W KR 2017004022W WO 2018026087 A3 WO2018026087 A3 WO 2018026087A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- enclomiphene
- sugar
- added
- preparation
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Abstract
본 발명에 따른 화학식 1의 화합물 또는 이의 약학적으로 허용가능한 염은 에스트로겐 수용체α(ERα)에 길항 활성을 유지하면서 생체이용률을 향상시키는 효과가 있는 당부가 엔클로미펜 유도체들로서, 골다공증(osteoporosis), 갱년기성 질 위축증(vaginal atrophy), 성교불쾌증(dyspareunia), 여유증(gynecomastia), 남성 이차 성선기능저하증 및 인슐린 비의존성 당뇨병 혹은 지방이영양증, 불임증, 남성전립선비대증, 전립선암, 난소암, 유방암 등의 에스트로겐 수용체 관련 질환을 치료할 수 있는 프로드럭 혹은 대체 개량 제형으로서 유용하게 사용될 수 있다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2016-0100098 | 2016-08-05 | ||
KR1020160100098A KR101970326B1 (ko) | 2016-08-05 | 2016-08-05 | 당 부가된 엔클로미펜, 이의 제조방법 및 이를 포함하는 약학적 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018026087A2 WO2018026087A2 (ko) | 2018-02-08 |
WO2018026087A3 true WO2018026087A3 (ko) | 2018-08-09 |
Family
ID=61074169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2017/004022 WO2018026087A2 (ko) | 2016-08-05 | 2017-04-13 | 당 부가된 엔클로미펜, 이의 제조방법 및 이를 포함하는 약학적 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101970326B1 (ko) |
WO (1) | WO2018026087A2 (ko) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001027127A1 (en) * | 1999-10-08 | 2001-04-19 | Strakan Group Plc | Tamoxifen and tamoxifen analogue glycosides and uses thereof |
KR20010108719A (ko) * | 2000-05-31 | 2001-12-08 | 추후보정 | 유방암의 예방 또는 치료용 조성물 및 그 예방 또는 치료방법 |
WO2009035652A1 (en) * | 2007-09-13 | 2009-03-19 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
KR20170011543A (ko) * | 2015-07-23 | 2017-02-02 | 고려대학교 산학협력단 | 당전이 효소를 이용한 당 부가된 에스트로겐 수용체 조절제의 제조방법 |
-
2016
- 2016-08-05 KR KR1020160100098A patent/KR101970326B1/ko active IP Right Grant
-
2017
- 2017-04-13 WO PCT/KR2017/004022 patent/WO2018026087A2/ko active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001027127A1 (en) * | 1999-10-08 | 2001-04-19 | Strakan Group Plc | Tamoxifen and tamoxifen analogue glycosides and uses thereof |
KR20010108719A (ko) * | 2000-05-31 | 2001-12-08 | 추후보정 | 유방암의 예방 또는 치료용 조성물 및 그 예방 또는 치료방법 |
WO2009035652A1 (en) * | 2007-09-13 | 2009-03-19 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
KR20170011543A (ko) * | 2015-07-23 | 2017-02-02 | 고려대학교 산학협력단 | 당전이 효소를 이용한 당 부가된 에스트로겐 수용체 조절제의 제조방법 |
Non-Patent Citations (1)
Title |
---|
MCCAGUE, R.: "Metabolism of tamoxifen by isolated rat hepatocytes: Identification of the glucuronide of 4-hydroxytamoxifen", BIOCHEMICAL PHARMACOLOGY, 1 May 1990 (1990-05-01), pages 1459 - 1465, XP025521625 * |
Also Published As
Publication number | Publication date |
---|---|
KR101970326B1 (ko) | 2019-04-18 |
KR20180016108A (ko) | 2018-02-14 |
WO2018026087A2 (ko) | 2018-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022005780A (es) | Moduladores de receptores estrogenicos. | |
WO2018140831A3 (en) | Tumor targeting conjugates and methods of use thereof | |
MX2020001235A (es) | Análogos de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona. | |
SG11201806348PA (en) | Steroid derivative fxr agonist | |
BR112016020953A2 (pt) | composto, kit, composição farmacêutica, uso de composto, método de tratamento e invenção | |
TN2018000395A1 (en) | New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
PH12018502535B1 (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
GEP20207160B (en) | New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
MX2017016376A (es) | Derivado de piperidina y metodo de preparacion y uso farmaceutico del mismo. | |
PH12015502524A1 (en) | New somatostatin receptor subtype 4 (sstr4) agonists | |
BR112015023948A2 (pt) | composto de fórmula (i), composição farmacêutica, método para o tratamento e/ou prevenção de uma doença proliferativa e para a inibição ou a diferenciação do crescimento de uma célula tronco do câncer | |
PH12016502539A1 (en) | Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators | |
MX2018007844A (es) | Derivado de benzopiperidina, metodo de preparacion del mismo y su uso medico del mismo. | |
MX2021010252A (es) | Inhibidores del receptor de glucocorticoides. | |
PH12015502557A1 (en) | Low dose pharmaceutical composition | |
PH12018500852A1 (en) | Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use | |
AU2018341781A8 (en) | Fused ring derivative as A2A receptor inhibitor | |
EA201490416A1 (ru) | Метаболиты транс-кломифена и их применение | |
PH12018501292A1 (en) | Pharmaceutical compositions comprising phenylaminopyridine derviative | |
PH12018500829A1 (en) | Novel heterocyclic antiestrogens | |
MY176521A (en) | Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising the same and use thereof | |
WO2018026087A3 (ko) | 당 부가된 엔클로미펜, 이의 제조방법 및 이를 포함하는 약학적 조성물 | |
WO2021071372A8 (en) | Process of vitamin k2 derivatives preparation | |
NZ702684A (en) | Hexadepsipeptide analogues as anticancer compounds | |
MX2019000542A (es) | Derivados de pirazolilaminobenzimidazol como inhibidores de jak. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17837139 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17837139 Country of ref document: EP Kind code of ref document: A2 |